-

Dr. Jidong Jia: Advances in Diagnosis and Treatment of Non-Cirrhotic Portal Hypertension
“Hepatology Digest”: In recent years, what are the major advances in the research of portal hypertension in China? Dr. Jidong Jia: Portal hypertension refers to a group of clinical syndromes caused by an…
-

Interview with Recipient of the “Huaxia Youth Medical Science and Technology Award”
This interview features Dr. Xiaolong Qi, a recipient of the Huaxia Youth Medical Science and Technology Award, one of the most prestigious awards in the Chinese medical field. The Huaxia…
-

“The Natural Course of Portal Vein Thrombosis in Cirrhosis.”
Article Summary Portal vein thrombosis (PVT) refers to the formation of a blood clot in the main trunk of the portal vein and/or its left and right branches, sometimes accompanied…
-

Chinese scientist awarded for groundbreaking work in transplantation, cellular therapy
SAN ANTONIO, the United States, Feb. 24 (Xinhua) — Chinese scientist Huang Xiaojun won a top international award here on Friday for his groundbreaking work known as Beijing Protocol in…
-

ESMO China Voice | Professor Bin Shao : Comprehensive Genomic Analysis of Advanced HR+/HER2- Breast Cancer Patients Using Liquid Biopsy
HR+/HER2- is the most common subtype of breast cancer, accounting for approximately 65% to 70% of all breast cancer cases. Improving the survival benefits for patients with advanced HR+/HER2- breast cancer has always been a hot topic in this field and a unanimous goal for scholars and experts. Exploring the genomic characteristics of advanced HR+/HER2-…
-

Prof. Jun Ma Highlights ASH Conference, Showcasing Chinese Influence on Global Stage
Local time on December 9th, the eagerly awaited 65th American Society of Hematology (ASH) Annual Meeting officially kicked off in San Diego, USA. The Oncology Insight reporting team delved into the forefront, witnessing the impressive presence of “The Voice of China” on the international stage. ASH is one of the largest and most comprehensive international…

